Online webinars
Watch our latest online webinars, where leading experts from around the world come to share discoveries and insights from research and clinical practice in prostate care.
Elevating Prostate Care with Ultrasound and Biopsy Solutions
Targeted MRI/US guided biopsies are the recommended methods for prostate detection. During the webinar, all the techniques of MR/US fusion-guided biopsy will be presented, as well as additional technologies for multi-parametric ultrasound imaging of the prostate, and an outlook on potential applications for ultrasound-guided focal treatment will be discussed.
Targeted MRI/US guided biopsies are the recommended methods for prostate detection. During the webinar, all the techniques of MR/US fusion-guided biopsy will be presented, as well as additional technologies for multi-parametric ultrasound imaging of the prostate, and an outlook on potential applications for ultrasound-guided focal treatment will be discussed.
Oncology Days | Prostate Cancer
The superior sensitivity of MRI also complements the ultrasound-guided biopsy in an innovative fusion technique to target a suspicious lesion and shortening your procedure time.
During the webinar, our speakers will share all the newest developments in the exciting field of prostate cancer together with the benefits of our technology in this field.
The superior sensitivity of MRI also complements the ultrasound-guided biopsy in an innovative fusion technique to target a suspicious lesion and shortening your procedure time.
During the webinar, our speakers will share all the newest developments in the exciting field of prostate cancer together with the benefits of our technology in this field.
White papers and case studies
Prostatic imaging with our MRI solutions
Guided targeted biopsy with our Smart Fusion technology
Advanced PET imaging solutions
Highlighted scientific publications
Prostate imaging with our MRI solutions
Deep Learning Reconstruction can improve image quality of MRI prostate scans
Study Overview:
Key Findings:
Conclusion:
Ueda T. et al. Deep Learning Reconstruction of Diffusion- weighted MRI Improves Image Quality for Prostatic Imaging. Radiology (2022).
- Participants: 60 male patients with biopsy- proven prostate cancer.
- Imaging Technique: Diffusion- weighted MRI (DWI) at b- values of 0, 1000, 3000, and 5000 sec/mm², reconstructed with and without deep learning reconstruction (DLR).
Key Findings:
- DWI with DLR showed significantly higher SNRs and CNRs than DWI without DLR
- Significantly higher mean image quality scores with DLR as compared to without.
- Apparent diffusion coefficient (ADC) values remained consistent regardless of DLR application, indicating no impact on quantitative measurements
Conclusion:
- “Deep learning reconstruction can improve the image quality of diffusion- weighted MRI scans of the prostate without affecting quantification of apparent diffusion coefficients, and has the potential to improve lesion characterization in patients with suspected prostate cancer.”
Ueda T. et al. Deep Learning Reconstruction of Diffusion- weighted MRI Improves Image Quality for Prostatic Imaging. Radiology (2022).
Guided targeted biopsy with our MR/US smart fusion solutions
Safety and efficacy of MR/US smart fusion for transperineal prostate biopsies
Study overview:
Results:
- 203 male patients with PI- RADS >2
- Transperineal prostate biopsy under local anaesthesia in an outpatient setting
- Canon Medical Aplio i800 with MR/US smart fusion software
Results:
- Cancer detection rate: Overall: 73.5% | Clinically significant: 60.1%
- Procedure duration: 22.5 min (≤15 min without systematic biopsy)
- Patient tolerance: Discomfort biopsy core sampling rated 1.6/10 (similar to lying on exam table: 1.5/10)
Conclusion:
De Vulder N. et al. Safety and efficacy of software- assisted MRI- TRUS fusion- guided transperineal prostate biopsy in an outpatient setting using local anaesthesia. Abdom Radiol (2023).
- Transperineal targeted biopsy with MRI- TRUS fusion software has high overall and clinically significant cancer detection rates. The method is well tolerated under local anaesthesia and in an outpatient setting.
De Vulder N. et al. Safety and efficacy of software- assisted MRI- TRUS fusion- guided transperineal prostate biopsy in an outpatient setting using local anaesthesia. Abdom Radiol (2023).
More recommended publications
Prostate imaging with our MRI solutions
Guided targeted biopsy with our MR/US smart fusion solutions
Advanced ultrasound solutions
- Ueda T. et al. Reverse encoding distortion correction for diffusion- weighted MRI: Efficacy for improving image quality and ADC evaluation for differentiating malignant from benign areas in suspected prostatic cancer patients. European Journal of Radiology (2023). https://doi.org/https://doi.org/10.1016/j.ejrad.2023.110764
Guided targeted biopsy with our MR/US smart fusion solutions
- Jelidi A. et al. Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRI- TRUS fusion method to target biopsies. European Journal of Radiology (2017). https://doi.org/10.1016/j.ejrad.2016.11.016
Advanced ultrasound solutions
- Correas J.- M. et al. Advanced ultrasound in the diagnosis of prostate cancer. World Journal of Urology (2021).
https://doi.org/10.1007/s00345-020-03193-0 - Matsugasumi T. et al. Intraoperative ultrasound monitoring with superb microvascular imaging in focal cryotherapy for prostate cancer. Journal of Medical Ultrasonics (2022).
https://doi.org/10.1007/s10396-022-01206-6
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems global webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
